CS-062 Interim Drug Testing Processes Standard

Clients shall be assessed for substance testing frequency using a combination of the Simple Screening Instrument – Revised (SSI-R), the Level of Supervision Inventory (LSI), and the results of the entry UA test pursuant to C.C.C.S. CS-061. Until such time an assessment is completed, clients shall be treated as high risk and tested at the frequency of once (1) per week.

The frequency for each client’s interim UA testing shall be based on the results of the substance involvement assessment, and the client’s residential (or non-residential) level.

A negative assessment for drug and/or alcohol involvement shall be defined as:

1. The SSI-R score is a total of three (3) or less AND
2. ​​​​​​​If LSI interview and/or collateral information indicates that there is no risk of current or recent substance use involvement AND
3. ​​​​​​​The initial full polysubstance UA administered pursuant to C.C.C.S. CS-061 shows a negative test for any of the following drugs: cocaine metabolite, THC, amphetamines, opiates, barbiturates, benzodiazepines, creatinine levels, and alcohol.

Clients who assess negative for drug and/or alcohol involvement (see above) shall be scheduled for interim full polysubstance UA testing according to the following schedule:

Table CS-062(A): SUBSTANCE TESTING GRID FOR NON-SUBSTANCE INVOLVED CLIENTS

In the event that a client is initially assessed as negative for drug and/or alcohol involvement and submits a positive test for any substance on any level of supervision, a client shall be scheduled on the SUBSTANCE TESTING GRID FOR SUBSTANCE INVOLVED CLIENTS in accordance with the programs written policies, procedures and established practices.

A positive assessment for substance involvement shall be defined as:

1. The SSI-R score is a total of four (4) or greater OR
2. If LSI interview and/or collateral information indicates that there is risk of current or recent substance use involvement, OR
3. The initial full polysubstance UA administered pursuant to C.C.C.S. CS-061 shows a positive test for any of the following drugs: cocaine metabolite, THC, amphetamines, opiates, barbiturates, benzodiazepines, creatinine levels, and alcohol.

A client who has a positive assessment for drug involvement shall be tested using a full polysubstance drug test in accordance with the minimum frequency levels with the SUBSTANCE TESTING GRID FOR SUBSTANCE INVOLVED CLIENTS, and shall address, at a minimum, the following expectations:

1. May be driven based on risk, i.e. TxRW or LSI
2. Frequency for Level 5 cannot be less than Level 4
3. Maximum of 8x per month for all levels*
4. Must taper across levels for Non-Residential
5. Level 5 - Level 8 must have supporting documentation for frequency above the minimum range
6. *Must be responsive to the unique risk and needs of the client
7. Specialty testing may be utilized in lieu of a full polysubstance drug test with supporting documentation; however, clients must have a minimum of one (1) full polysubstance drug test per month.

A client who has a positive assessment shall be tested using breath analysis in accordance with the programs written policies, procedures and established practices.

Table CS-062(B): SUBSTANCE TESTING GRID FOR SUBSTANCE INVOLVED CLIENTS

Programs shall treat dilute UAs as a positive result.

All urinalysis results must be returned within three (3) business days to ensure swiftness of the program’s response.

CS-062 Intent/Clarification:

Testing rates represent minimum testing requirements. Programs shall choose testing frequencies and/or additional criteria using the SUBSTANCE TESTING GRID FOR SUBSTANCE INVOLVED CLIENTS and minimum expectations (located above) for testing substance involved clients. More frequent testing may be indicated for some clients based on case assessment or requests by referring agencies.

It is recommended that testing not exceed two (2) times per week, as this may not detect new use of a substance.

Substance testing levels shall not be used to infer severity, recency, frequency, history, and intensity. UA testing shall be unexpected, unannounced, and unanticipated by the client. (Information/research provided by National Drug Court of Drug Court Professional Adult Drug Court Best Practice Standards).

Clients shall be assessed for substance testing frequency using a combination of the Simple Screening Instrument – Revised (SSI-R), the Level of Supervision Inventory (LSI), and the results of the entry UA test pursuant to C.C.C.S. CS-061. Until such time an assessment is completed, clients shall be treated as high risk and tested at the frequency of four (4) times per month.

The frequency for each client’s interim UA and/or BA testing shall be based on the results of the substance involvement assessment. For non-residential levels, the client’s level will also be utilized to determine frequency.

A negative assessment for drug and/or alcohol involvement shall be defined as:

1. The SSI-R score is a total of three (3) or less AND
2. If LSI interview and/or collateral information indicates that there is no risk of current or recent substance use involvement AND
3. The initial full polysubstance UA administered pursuant to C.C.C.S. CS-061 shows a negative test for any of the following drugs: cocaine metabolite, THC, amphetamines, opiates, barbiturates, benzodiazepines, creatinine levels, and alcohol.

Clients who assess negative for drug and/or alcohol involvement (see above) shall be scheduled for interim full polysubstance UA testing once a month.

In the event that a client is initially assessed as negative for drug and/or alcohol involvement and submits a positive test for any substance on any level of supervision, a client shall be scheduled as a Substance Involved client.

A positive assessment for substance involvement shall be defined as:

1. The SSI-R score is a total of four (4) or greater OR
2. If LSI interview and/or collateral information indicates that there is risk of current or recent substance use involvement, OR
3. The initial full polysubstance UA administered pursuant to C.C.C.S. CS-061 shows a positive test for any of the following drugs: cocaine metabolite, THC, amphetamines, opiates, barbiturates, benzodiazepines, creatinine levels, and alcohol.

A client who has a positive assessment for drug involvement shall be tested using a full polysubstance drug test in accordance with the minimum frequency of 4 times a month.

A client who has a positive assessment limited to alcohol involvement shall be tested using breath analysis OR urinalysis in accordance with the minimum frequency.

Table CS-062(A): SUBSTANCE TESTING GRID FOR RESIDENTIAL CLIENTS

Table CS-062(B): SUBSTANCE TESTING FOR NON-RESIDENTIAL CLIENTS

Programs shall treat dilute UAs as a positive result.

All urinalysis results must be returned within three (3) business days to ensure swiftness of the program’s response.

Intent/Clarification: More frequent testing may be indicated for some clients based on case assessment or requests by referring agencies.

Substance testing levels shall not be used to infer severity, recency, frequency, history, and intensity. UA testing shall be unexpected, unannounced, and unanticipated by the client. (Information/research provided by National Drug Court of Drug Court Professional Adult Drug Court Best Practice Standards).

Clients shall be assessed for substance testing frequency using a combination of the Simple Screening Instrument – Revised (SSI-R), the Level of Supervision Inventory (LSI), and the results of the entry UA test pursuant to C.C.C.S. CS-061. Until such time an assessment is completed, clients shall be treated as high risk and tested at the frequency of eight (8) times per month.

The frequency for each client’s interim UA and/or BA testing shall be based on the results of the substance involvement assessment, the client’s risk level and residential (or non-residential) level.

A negative assessment for drug and/or alcohol involvement shall be defined as: 

1. The SSI-R score is a total of three (3) or less AND
2. If LSI interview and/or collateral information indicates that there is no risk of current or recent substance use involvement AND
3. The initial full polysubstance UA administered pursuant to C.C.C.S. CS-061 shows a negative test for any of the following drugs: cocaine metabolite, THC, amphetamines, opiates, barbiturates, benzodiazepines, creatinine levels, and alcohol.

Clients who assess negative for drug and/or alcohol involvement (see above) shall be scheduled for interim full polysubstance UA testing according to the following schedule:

Table 1 CS-062(A): SUBSTANCE TESTING GRID FOR NON-SUBSTANCE INVOLVED CLIENTS

In the event that a client is initially assessed as negative for drug and/or alcohol involvement and submits a positive test for any substance on any level of supervision, a client shall be scheduled on the RISK-BASED AND PROGRAM LEVEL BASED SUBSTANCE TESTING GRID  in accordance with their current risk level and program level.

A positive assessment for substance involvement shall be defined as:

1. The SSI-R score is a total of four (4) or greater OR
2. If LSI interview and/or collateral information indicates that there is risk of current or recent substance use involvement, OR
3. The initial full polysubstance UA administered pursuant to C.C.C.S. CS-061 shows a positive test for any of the following drugs: cocaine metabolite, THC, amphetamines, opiates, barbiturates, benzodiazepines, creatinine levels, and alcohol.

A client who has a positive assessment for drug involvement shall be tested using a full polysubstance drug test in accordance with the minimum frequency levels within either the FOUR (4) or TWO (2) TIERED RISK-BASED AND PROGRAM LEVEL BASED SUBSTANCE TESTING GRID.

A client who has a positive assessment limited to alcohol involvement shall be tested using breath analysis OR urinalysis in accordance with the minimum frequency levels within either the FOUR (4) or TWO (2) TIERED RISK-BASED AND PROGRAM LEVEL BASED SUBSTANCE TESTING GRID.

Table 2 CS-062(B): FOUR (4) TIERED RISK AND PROGRAM LEVEL BASED SUBSTANCE TESTING GRID

Table 3 CS-062(C): TWO (2) TIERED RISK AND PROGRAM LEVEL BASED SUBSTANCE TESTING GRID

Programs shall treat dilute UAs as a positive result.

All urinalysis results must be returned within three (3) business days to ensure swiftness of the program’s response.

Intent/Clarification: Testing rates represent minimum testing requirements. Programs shall choose either the four (4) tiered table (B) or two (2) tiered table (C) RISK-BASED AND PROGRAM LEVEL BASED SUBSTANCE TESTING GRID (located above) for testing substance involved clients. More frequent testing may be indicated for some clients based on case assessment or requests by referring agencies.

Substance testing levels shall not be used to infer severity, recency, frequency, history, and intensity. UA testing shall be unexpected, unannounced, and unanticipated by the client. (Information/research provided by National Drug Court of Drug Court Professional Adult Drug Court Best Practice Standards).